+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Phase 2
Age: 50Years +
All Genders
ID07693140

Phase III Study Evaluating Low-Dose Whole Brain Radiotherapy for Alzheimers Disease and Inflammatory Dementias

Led by Evan Thomas · Updated on 2026-07-09

50

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and tolerability of low-dose whole brain radiotherapy WBRT in patients aged 50 years or older with Alzheimers disease or other dementias that have inflammatory components. This Phase III study aims to assess a new approach of delivering brain radiation in an induction course followed by monthly maintenance doses over a year to understand its effects on this condition. Participants receive low-dose whole brain radiotherapy as an induction treatment consisting of 10 fractions at 0.3 Gy each, totaling 3.0 Gy. After a two-month break, they begin a maintenance phase where they receive 10 more fractions monthly over 12 months, also at 0.3 Gy each. This treatment schedule is designed to study the tolerability and impact of repeated low-dose radiation on Alzheimers and related dementias. Throughout the study, participants are monitored for safety, focusing on any treatment-related adverse events of grade 3 or higher from the first radiation session through about 13 to 15 months. Cognitive function is also tracked using the Montreal Cognitive Assessment MoCA score over the maintenance period, with a key assessment at month 12. Participants need to attend monthly clinic visits and be accompanied by a reliable caregiver for most visits. The trial spans approximately this duration to carefully assess both safety and cognitive preservation.

CONDITIONS

Brief Title

Low-Dose Radiotherapy for Alzheimer's Disease

Research Team

J

Julia Pierson, BS

A

Anita Stolaruk, RTT, MBA

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here